Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rusnano will jointly work with Russian Federal Medical-Biological Agency (FMBA) Vladimir Uiba for safe production and safe application of nanotechnology and nanomaterials. The agreement was signed between Anatoly Chubais, CEO of Rusnano and head of the Russian FMBA Vladimir Uiba.
Subscribe to our email newsletter
Collaboration between the two organizations will ensure the sanitary and epidemiological well being of the country’s inhabitants during scientific research, development work, production, consumption, and disposal of products, materials, and finished goods created with nanomaterials and nanotechnology and during commercialization of nanotechnology for practical applications in medicine and pharmacology.
Under the agreement, Rusnano and FMBA are entrusted with developing technical and organizational measures to safeguard production and use of nanomaterials, nanotechnology, and products of the nanoindustry. In other areas of cooperation, they will introduce nanobiotechnology for applied uses in medicine and pharmacology, create new types of medicaments and new methods for diagnosis and treatment of socially significant and job-related illnesses, and devise effective means for detoxification and individual protection.
Rusnano and FMBA will have a role in regulations as well, proposing laws and norms to guarantee safe conditions for scientific investigations, development work, production, consumption, and disposal of products, materials, and finished goods created with nanomaterials and nanotechnology.